Product
Placebo Nasal Spray
2 clinical trials
3 indications
Indication
Cancer PainIndication
AnxietyIndication
Acute AnxietyClinical trial
IMPORTANCE Trial - A Provisional Study-design of a Single-center, Phase II, Double-blinded, Placebo-controlled, Randomized, 4-week Study to Compare the Efficacy and Safety of Intranasal Esketamine in Chronic Opioid Refractory PainStatus: Withdrawn, Estimated PCD: 2023-10-11
Clinical trial
Administration of Intranasal Midazolam for Anxiety in Palliative Care - a Double-blind, Randomized, Placebo-controlled Multicenter Exploratory Pilot Study With a Nested Pharmacokinetic AnalysisStatus: Not yet recruiting, Estimated PCD: 2024-10-31